A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block “eat-me” signal

Immune checkpoint inhibitors (ICIs) have induced durable clinical responses in a subset of patients with colorectal cancer (CRC). However, the dis-satisfactory response rate and the lack of appropriate biomarkers for selecting suitable patients to be treated with ICIs pose a major challenge to curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Min, Wang, Xueping, Wu, Shaocong, Yang, Chuan, Su, Qiao, Huang, Lamei, Fu, Kai, An, Sainan, Xie, Fachao, To, Kenneth Kin Wah, Wang, Fang, Fu, Liwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444827/
https://www.ncbi.nlm.nih.gov/pubmed/37607946
http://dx.doi.org/10.1038/s41392-023-01545-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444827/
https://www.ncbi.nlm.nih.gov/pubmed/37607946
http://dx.doi.org/10.1038/s41392-023-01545-x

Ejemplares similares